Targeting Elastin-Derived Peptides Reverses Alveolar Epithelial Dysfunction in Chronic Obstructive Pulmonary Disease

Area of Science:

• Pulmonary Medicine
• Cell Biology
• Biochemistry

Background:

• Chronic obstructive pulmonary disease (COPD) involves alveolar destruction and impaired regeneration.
• Matrix-derived factors mediating this process are not well understood.
• Cigarette smoke (CS) induces elastin degradation, generating bioactive elastin-derived peptides (EDPs).

Purpose of the Study:

• To investigate the role of EDPs in alveolar epithelial dysfunction in COPD.
• To explore EDPs as potential mediators of impaired alveolar regeneration.
• To assess EDP-neutralizing agents as a therapeutic strategy.

Main Methods:

• Analysis of human COPD lung tissues and CS-exposed mouse models.
• Histological examination and single-cell transcriptomic profiling.
• Functional assays using mouse and human alveolar organoids.
• Investigation of signaling pathways including TLR4/NF-κB and β-catenin.
• Evaluation of an EDP-neutralizing agent (TB) in vitro and in vivo.

Main Results:

• Elevated EDPs correlated with elastic fiber disruption and impaired alveolar type 2 (AT2)-to-alveolar type 1 (AT1) differentiation in COPD and CS models.
• CS extract and EDPs suppressed alveolar organoid growth and AT2-to-AT1 differentiation.
• EDPs activated TLR4/NF-κB signaling and reduced β-catenin activity.
• TLR4 inhibition and TB treatment partially restored alveolar differentiation and alleviated emphysema.
• TB partially rescued AT2-to-AT1 differentiation in organoids and alleviated emphysematous injury in vivo.

Conclusions:

• EDPs are significant matrix-derived mediators of alveolar regenerative failure in COPD.
• EDP-targeted interventions show potential for promoting alveolar repair.
• Understanding EDPs' role offers new therapeutic avenues for COPD treatment.